tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IONS Stock Latest News

Ionis Pharmaceuticals ups FY25 revenue view to $725M-$750M from at least $600M
The FlyIonis Pharmaceuticals ups FY25 revenue view to $725M-$750M from at least $600M
2h ago
IONS
Ionis Pharmaceuticals reports Q1 EPS (93c), consensus ($1.03)
PremiumThe Fly
Ionis Pharmaceuticals reports Q1 EPS (93c), consensus ($1.03)
3h ago
IONS
IONS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
IONS Earnings this Week: How Will it Perform?
2d ago
IONS
Ionis Pharmaceuticals’ Tryngolza: Promising Treatment for Severe Hypertriglyceridemia with Strong Market Potential
PremiumRatings
Ionis Pharmaceuticals’ Tryngolza: Promising Treatment for Severe Hypertriglyceridemia with Strong Market Potential
15d ago
IONS
Buy Rating for Ionis Pharmaceuticals: Promising Potential of Olzesarsen in sHTG Treatment
PremiumRatings
Buy Rating for Ionis Pharmaceuticals: Promising Potential of Olzesarsen in sHTG Treatment
15d ago
IONS
Promising Potential of Ionis Pharmaceuticals’ Olezarsen in sHTG Market with Competitive Pricing and Strong Market Potential
PremiumRatingsPromising Potential of Ionis Pharmaceuticals’ Olezarsen in sHTG Market with Competitive Pricing and Strong Market Potential
15d ago
IONS
Ionis Pharmaceuticals: Promising Market Growth with Tryngolza Approval and Advancing Clinical Trials
Premium
Ratings
Ionis Pharmaceuticals: Promising Market Growth with Tryngolza Approval and Advancing Clinical Trials
15d ago
IONS
Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley
Premium
The Fly
Ionis Pharmaceuticals price target lowered to $52 from $55 at Morgan Stanley
19d ago
IONS
Ionis Pharmaceuticals: Promising Growth with New Product Launches and Strong Pipeline
PremiumRatings
Ionis Pharmaceuticals: Promising Growth with New Product Launches and Strong Pipeline
22d ago
IONS
Reddit initiated, Roku upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Reddit initiated, Roku upgraded: Wall Street’s top analyst calls
23d ago
DG
GM
Ionis Pharmaceuticals: Poised for Growth with Promising RNA-Targeted Therapeutics and Upcoming Drug Launches
PremiumRatings
Ionis Pharmaceuticals: Poised for Growth with Promising RNA-Targeted Therapeutics and Upcoming Drug Launches
23d ago
IONS
Ionis Pharmaceuticals initiated with a Buy at H.C. Wainwright
PremiumThe Fly
Ionis Pharmaceuticals initiated with a Buy at H.C. Wainwright
23d ago
IONS
Ionis Pharmaceuticals management to meet with Oppenheimer
PremiumThe FlyIonis Pharmaceuticals management to meet with Oppenheimer
26d ago
IONS
Promising Potential of Ionis Pharmaceuticals’ Pelacarsen Drives Buy Rating Amidst Phase 3 HORIZON Trial Optimism
Premium
Ratings
Promising Potential of Ionis Pharmaceuticals’ Pelacarsen Drives Buy Rating Amidst Phase 3 HORIZON Trial Optimism
26d ago
IONS
Ionis Pharmaceuticals initiated with a Neutral at Redburn Atlantic
Premium
The Fly
Ionis Pharmaceuticals initiated with a Neutral at Redburn Atlantic
1M ago
IONS
Ionis Pharmaceuticals enters exclusive olezarsen license agreement with Sobi
PremiumThe Fly
Ionis Pharmaceuticals enters exclusive olezarsen license agreement with Sobi
1M ago
IONS
Ionis Pharmaceuticals price target lowered to $45 from $47 at JPMorgan
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $45 from $47 at JPMorgan
1M ago
IONS
Metagenomi price target lowered to $20 from $25 at Wells Fargo
PremiumThe Fly
Metagenomi price target lowered to $20 from $25 at Wells Fargo
1M ago
MGX
IONS
Ionis Pharmaceuticals: Strategic Partnerships and Financial Flexibility Drive Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strategic Partnerships and Financial Flexibility Drive Buy Rating
1M ago
IONS
Ionis Pharmaceuticals and Ono announce license agreement for sapablursen
PremiumThe FlyIonis Pharmaceuticals and Ono announce license agreement for sapablursen
2M ago
IONS
Ionis and AstraZeneca’s WAINZUA gets EU approval for ATTRv-PN treatment
Premium
The Fly
Ionis and AstraZeneca’s WAINZUA gets EU approval for ATTRv-PN treatment
2M ago
AZN
IONS
Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives
Premium
Ratings
Optimistic Future Outlook for Ionis Pharmaceuticals Driven by Robust Growth and Strategic Initiatives
2M ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >